Related Experiment Video
Updated: Mar 14, 2026
Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Knockdown of CUL4B Suppresses the Proliferation and Invasion in Non-Small Cell Lung Cancer Cells
1Department of Thoracic Surgery, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China.
Abstract:
Cullin 4B (CUL4B), a scaffold protein that assembles CRL4B ubiquitin ligase complexes, was found to be overexpressed in many types of tumors. However, the expression pattern and role of CUL4B in non-small cell lung cancer (NSCLC) remain largely unknown. Therefore, in the present study, we investigated the role of CUL4B in NSCLC, and the underlying mechanism was also explored. Our results showed that CUL4B was highly expressed in NSCLC cell lines. Silencing CUL4B obviously inhibited proliferation and migration/invasion of NSCLC cells, and it also suppressed the epithelial-mesenchymal transition (EMT) progress in NSCLC cells. Furthermore, knockdown of CUL4B significantly inhibited the expression of β-catenin, cyclin D1, and c-Myc in NSCLC cells. Taken together, these results suggest that knockdown of CUL4B inhibited the proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway in NSCLC cells. Therefore, CUL4B may represent a novel therapeutic target for the treatment of NSCLC.
Insights
Cullin 4B (CUL4B) is overexpressed in non-small cell lung cancer (NSCLC). Silencing CUL4B inhibits NSCLC cell proliferation and invasion by suppressing the Wnt/β-catenin pathway, suggesting CUL4B as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cullin 4B (CUL4B) is a scaffold protein involved in ubiquitin ligase complexes.
- CUL4B overexpression is observed in various cancers, but its role in non-small cell lung cancer (NSCLC) is unclear.
Purpose of the Study:
- To investigate the expression pattern and functional role of CUL4B in NSCLC.
- To explore the underlying molecular mechanisms of CUL4B's action in NSCLC.
Main Methods:
- Assessed CUL4B expression in NSCLC cell lines.
- Utilized CUL4B silencing (knockdown) to evaluate its effects on NSCLC cell behavior.
- Analyzed the impact of CUL4B knockdown on epithelial-mesenchymal transition (EMT) and key signaling pathway components.
Main Results:
- CUL4B was found to be highly expressed in NSCLC cell lines.
- CUL4B silencing significantly inhibited NSCLC cell proliferation, migration, and invasion.
- Knockdown of CUL4B suppressed EMT and downregulated key proteins including β-catenin, cyclin D1, and c-Myc.
Conclusions:
- CUL4B promotes NSCLC progression by activating the Wnt/β-catenin signaling pathway.
- CUL4B inhibition effectively suppresses proliferation and invasion in NSCLC.
- CUL4B represents a promising novel therapeutic target for NSCLC treatment.
Related Concept Videos
02:34Inhibition of Cdk Activity
02:34Inhibition of CDK Activity
02:23Abnormal Proliferation
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...